AbbVie News

AbbVie | 25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)

May 17 09:07 ET

AbbVie | PX14A6G: Notice of exempt solicitation

Apr 2 16:09 ET

AbbVie | PX14A6G: Notice of exempt solicitation

Mar 26 14:35 ET

AbbVie | 144/A: Others

Mar 21 14:32 ET

AbbVie | ARS: Annual Report to Security Holders

Mar 18 16:30 ET

AbbVie | 25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)

Nov 15, 2023 13:32 ET

AbbVie | SD: Specialized disclosure report

May 31, 2023 16:59 ET

AbbVie | PX14A6G: Notice of exempt solicitation

May 4, 2023 08:08 ET

AbbVie | PX14A6G: Notice of exempt solicitation

Apr 20, 2023 15:39 ET

AbbVie | PX14A6G: Notice of exempt solicitation

Apr 11, 2023 12:34 ET

AbbVie | PX14A6G: Notice of exempt solicitation

Mar 28, 2023 11:57 ET

AbbVie | PX14A6G: Notice of exempt solicitation

Mar 27, 2023 18:10 ET

AbbVie | ARS: Annual Report to Security Holders

Mar 21, 2023 17:21 ET

AbbVie | UPLOAD: Others

Oct 20, 2022 15:30 ET

AbbVie | CORRESP: CORRESP

Oct 4, 2022 12:01 ET

AbbVie | UPLOAD: Others

Sep 20, 2022 15:30 ET

AbbVie | SD: Specialized disclosure report

May 31, 2022 17:01 ET

AbbVie | PX14A6G: Notice of exempt solicitation

Apr 11, 2022 16:35 ET

AbbVie | PX14A6G: Notice of exempt solicitation

Apr 4, 2022 08:36 ET

AbbVie | PX14A6G: Notice of exempt solicitation

Mar 30, 2022 16:39 ET